CCL2/Monocyte Chemoattractant Protein-1 Mediates Enhanced Transmigration of Human Immunodeficiency Virus (HIV)-Infected Leukocytes across the Blood–Brain Barrier: A Potential Mechanism of HIV–CNS Invasion and NeuroAIDS | Journal of Neuroscience
Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage - Guo - 2020 - The FASEB Journal - Wiley Online Library
CCL2 disrupts the adherens junction: implications for neuroinflammation - ScienceDirect
Frontiers | Activated Microglia Disrupt the Blood-Brain Barrier and Induce Chemokines and Cytokines in a Rat in vitro Model
IJMS | Free Full-Text | The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials
Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies - The Lancet Neurology
Pharmaceuticals | Free Full-Text | Dysregulation of Blood-Brain Barrier and Exacerbated Inflammatory Response in Cx47-Deficient Mice after Induction of EAE
IJMS | Free Full-Text | Visfatin Mediates SCLC Cells Migration across Brain Endothelial Cells through Upregulation of CCL2
Interaction of dendritic cells with the blood-brain barrier. Through... | Download Scientific Diagram
IJMS | Free Full-Text | Links between Immune Cells from the Periphery and the Brain in the Pathogenesis of Epilepsy: A Narrative Review
Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage - Guo - 2020 - The FASEB Journal - Wiley Online Library
Frontiers | Pathophysiology of Blood–Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery
CCL2 disrupts the adherens junction: implications for neuroinflammation - ScienceDirect
Blood-Brain Barrier CCL2/MCP-1 Signaling Pathway: R&D Systems
CCL2 disrupts the adherens junction: implications for neuroinflammation | Laboratory Investigation
Strategies for delivering therapeutics across the blood–brain barrier | Nature Reviews Drug Discovery
Frontiers | Study of BBB Dysregulation in Neuropathogenicity Using Integrative Human Model of Blood–Brain Barrier
Frontiers | Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke | American Journal of Physiology-Cell Physiology
Human CCL2/JE/MCP-1 Antibody MAB279-100: R&D Systems
CCL2 (C-C Motif Chemokine Ligand 2) Biomarker Responses in Central Versus Peripheral Compartments After Focal Cerebral Ischemia | Stroke
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke | American Journal of Physiology-Cell Physiology
Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage - Guo - 2020 - The FASEB Journal - Wiley Online Library
CCL2 disrupts the adherens junction: implications for neuroinflammation - ScienceDirect
IJMS | Free Full-Text | Microglia and the Blood–Brain Barrier: An External Player in Acute and Chronic Neuroinflammatory Conditions
CCL2 disrupts the adherens junction: implications for neuroinflammation | Laboratory Investigation
CCL2 disrupts the adherens junction: implications for neuroinflammation | Laboratory Investigation
